Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

filgrastim

filgrastim
Drug Name Form Strength Notes
Neupogen and biosimilars SOLUTION, INJECTABLE 300 mcg/ 0.5 mL
Neupogen and biosimilars SOLUTION, INJECTABLE 480 mcg/1.6 mL
Releuko INJECTION, INJECTABLE 300 mcg; 480 mcg Legacy Hospitals preferred

VIEW MORE Hematopoietic Agents
CLASS
201600

Additional Information:

Releuko (filgrastim-ayow) is the inpatient preferred filgrastim product in Legacy Hospitals.

Nivestym (filgrastim- aafi) may be used for pediatric doses, since this is supplied in a vial rather than prefilled syringe (conducive to pediatric dosing).

 


Last updated: Jul. 1, 2025







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.